Clinical Trial Update: A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia [Phase 1]

View source ↗

Summary

This update reports results from a Phase 1 dose-escalation study evaluating the combination of bortezomib and lenalidomide in patients with myelodysplastic synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Revlimid (lenalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Myelodysplasia | Phase 1 | Status: COMPLETED